PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC13138602::ACT044663

Phoenixin-14 amide

Evidence text

Paper-level observation

Treatment with PNX-14 at 2.5 nmol significantly reduced atresia (7.0 ± 1.1; P < 0.01), with similar improvements at 5 and 30 nmol (Fig. 3H).
textConfidence: medium

Assay observation

Activity
Metabolic/Cardiovascular
Subtype
Other
Measure
other
Comparator
=
Raw observation
7.0 ± 1.1 count
Normalized measurement
=7 other
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Rattus norvegicus
Assay method
Not reported by source
Sequence
DVQPPGLKVWSDPFNH
Standardization
ready simple
Assay conditions
"original_unit=count"

Source publication

Phoenixin-14 ameliorates ovarian morphology in a DHEA-induced rat model of PCOS

Reproduction & Fertility · 2026

DOI 10.1530/RAF-25-0142 PMC13138602
Parent mention

Related peptide identities

PEPDIA-PLP-000501

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.